Tuesday, June 30, 2015

Life Spot Capital AG will be the first e-health technology and … – FinanzNachrichten.de

Life Spot Capital AG will be the first E-Health
 Technology and solutions in the stock market

DGAP-News: Life Spot Capital AG / Key word (s):
 Participation / Unternehmensbeteiligung / Change of Personnel Life Spot Capital AG
 presents itself as the first e-Health technology and
 Solution providers in the stock market

30.06.2015 / 08:05

Press release the Life Spot Capital AG

Life Spot Capital AG presents itself as the first e- Health
 Technology and solutions in the stock market

– focus on telemedicine solutions and Medical Big Data

– With BodyTel GmbH and Life Spot AG two innovative investments in
 Other planned takeovers of established e-health company

Hamburg / Munich, 30.06.2015 – –

which is listed on the Hamburg Stock Exchange
 former NBIC Capital AG (ISIN DE000A0DNBJ4) has, as in the
 Announced shareholders’ meeting on 30.12.2014, a new strategic
 aligned. Immediately it presents itself under the name
 Life Spot Capital AG, with new Executive Board members, and two new
 Investments from the promising e-health market at the

The Life Spot Capital AG develops solutions for digitizing the
 Health and the realization of interoperability, the
 Exchange of information of different systems and techniques
 medical field, at home and abroad. The focus is in front
 due to the improvement of patient care and the creation of
 a reliable, secure and standardized
 Communication structure between patients and providers of
 Health Services placed. In addition, will the
 Society functions of the booming wearables as
 Fitness bands and Smart Watches, with a medical monitoring,
 the combined connected with an app and database
 important preventive added value for patients, physicians and
 Pension provider offers, complete.

Currently has the Life Spot Capital AG two owns 100% subsidiaries
 in the portfolio. The BodyTel GmbH is a for several years on the market
 established German manufacturer and provider of telemedical
 Total solutions with permanent establishment in Bad Wildungen. The Company
 has specialized in the development of innovative, medical
 Communication platforms and devices, for example, to monitor
 chronic diseases, specialized. The dermatological
 Application of Life Spot AG developed an expert system,
 which offers the possibility of a reliable First Opinion
 obtain a dermatological disease. Here outbids the
 Companies among other doctors the possibility already
 to pledge or detailed diagnosed diseases
 Retrieve information to document diseases and their
 To monitor progress. Based on a neuronal image and
 Pattern Recognition software provides a dermatological application
 Unique selling point, which in the future to other
 Medical conditions and indications can be transferred.

As part of a buy-and-build strategy is the Life Spot Capital AG
 through the acquisition of well-established e-health company to
 powerful group in a highly attractive and fast-growing
 Future market be extended.

“Our goal is that Life Spot Group as a long-term
 to establish profitable technology companies and unique
 Synergy and cross-selling potential to lift, “explains Dr. Harald
 Dörsch, CEO of Life Spot Capital AG. The
 experienced managers has extensive international
 Expertise in the fields of medical technology, IT, pharmaceuticals and life
 Science and can on a stable, international network
 recourse. Dr. Dörsch has for well-known companies such as
 DaimlerChrysler Aerospace, Siemens, B2X, Bosch, B.Braun Aesculap and
 worked. Beside him Sabrina Müller was appointed to the Board. In
 With its many years as Head Marketing, Investor and
 Public Relations a listed investment company,
 responsible for them in addition to the capital market communication and
 Positioning In addition, the Life Science portfolio with the
 Focus E-Health.

Following the realignment is a relocation of the company headquarters
 to Munich and the listing in the continuous trading
 Munich Stock Exchange planned

About the Life Spot Capital AG:.

The Life Spot Capital AG is a technology and solutions provider in the
 Growth field eHealth and is a full service
 Telemedicine specialist. For this, the Life Spot Capital AG bundles its
 Technologies and solutions in operational units or
 Subsidiaries that focus on telemedicine solutions
 Medical and Big Data are specialized and takes the role
 the parent company of this one e-health network. Based
 a solid organic growth involved the Life Spot
 Capital AG as part of a buy-and-build strategy through
 established majority takeovers of already on the market
 EHealth companies. The company pursues the goal of the
 Life Spot Group to a profitable long term
 Technology company in an attractive market segment
 expand. Currently listed the shares on the Hamburg Stock Exchange under
 the ticker symbol CDZ, ISIN: DE000A0DNBJ4

Contact Life Spot Capital AG: Sabrina Müller Public & amp;. Investor
 Relations Denisstr. 1b D-80335 München Tel: +49 – 89-244-192-200
 Fax: +49 – 89-244-192-230 sabrina.mueller (at) lifespotcapital.com

ISIN: DE000A0DNBJ4 | WKN: A0DNBJ | Symbol: CDZ

30.06.2015 Dissemination of a Corporate News / financial news
 transmitted by DGAP – a service of EQS Group AG. For the
 Content of this announcement is the issuer / publisher responsible.

DGAP’s Distribution Services include Regulatory Announcements,
 Financial / Corporate News and Press Releases.
 Media archive at and http://www.dgap-medientreff.de

373 261 30.06.2015


AXC0043 2015-06-30 / 08: 05


No comments:

Post a Comment